Nonalcoholic Fatty Liver Disease and Fibrosis Progression: The Good, the Bad, and the Unknown Stephen A. Harrison, MD, FACP Clinical Gastroenterology and Hepatology Volume 13, Issue 4, Pages 655-657 (April 2015) DOI: 10.1016/j.cgh.2014.11.024 Copyright © 2015 AGA Institute Terms and Conditions
Figure 1 Fibrosis progression that is likely to occur in a group of 100 NAFLD patients. Approximately 33 patients will experience fibrosis progression over time. Of the fibrosis progressors, approximately 20%, or 7 patients, will experience rapid progression. Clinical Gastroenterology and Hepatology 2015 13, 655-657DOI: (10.1016/j.cgh.2014.11.024) Copyright © 2015 AGA Institute Terms and Conditions